Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estelle pharmacokinetics, safety, and QT study in healthy women
NL-OMON43025Active, not recruiting
- Sponsor
- Estetra SRL
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of estetrol + drospirenone, estetrol and drospirenone in contraception (4 arms), sponsored by Estetra SRL. Primary endpoint: Pharmacokinetics of estetrol in combination with drospirenone. Started Apr 2016; status: active, not recruiting.
02
Drugs
estetrol + drospirenoneestetroldrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON43025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43025.